» Articles » PMID: 27157104

Bone Metabolism During Pregnancy

Overview
Publisher Elsevier
Specialty Endocrinology
Date 2016 May 10
PMID 27157104
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

During pregnancy, mineral concentrations, of calcium and phosphorus in particular, are maintained at a high level in fetal blood so that the developing skeleton may accrete adequate mineral content. The placenta actively transports minerals for this purpose. Maternal intestinal absorption increases in order to meet the fetal demand for calcium, which is only partly dependent on calcitriol. Mineral regulation is essentially dependent on parathyroid hormone (PTH) and PTH-related protein (PTHrP). The calcium-sensing receptor (CaSR) regulates PTH and PTHrP production. If calcium intake is insufficient, the maternal skeleton will undergo resorption due to PTHrP. After birth, a switch from fetal to neonatal homeostasis occurs through increase in PTH and calcitriol, and developmental adaptation of the kidneys and intestines with bone turnover contributing additional mineral to the circulation. Calcium absorption becomes progressively active and dependent on calcitriol. The postnatal skeleton can transiently present with osteoposis but adequate mineral diet usually allows full restoration. Cases of primary osteoporosis must be identified. Loss of trabecular mineral content occurs during lactation in order to provide calcium to the newborn. This programmed bone loss is dependent on a "brain-breast-bone" circuit. The physiological bone resorption during reproduction does not normally cause fractures or persistent osteoporosis. Women who experience fracture are likely to have other causes of bone loss.

Citing Articles

Markers of Maternal Bone and Renal Toxicity Through 50 Weeks Postpartum: IMPAACT 2010 (VESTED) Trial.

Masheto G, Brummel S, Ziemba L, Shepherd J, Mbengeranwa T, Igawa L J Acquir Immune Defic Syndr. 2024; 97(2):172-179.

PMID: 39250651 PMC: 11384307. DOI: 10.1097/QAI.0000000000003478.


Consideration of hormonal changes for orthodontic treatment during pregnancy and lactation - a review.

Zhao Y, Qian S, Zheng Z, Peng J, Liu J, Guan X Reprod Biol Endocrinol. 2024; 22(1):106.

PMID: 39164703 PMC: 11334371. DOI: 10.1186/s12958-024-01281-z.


COVID-19 and Pregnancy: A Dangerous Mix for Bone Turnover and Metabolism Biomarkers in Placenta and Colostrum.

Diaz-Castro J, Toledano J, Sanchez-Romero J, Aguilar A, Martin-Alvarez E, Puche-Juarez M J Clin Med. 2024; 13(7).

PMID: 38610889 PMC: 11012405. DOI: 10.3390/jcm13072124.


The effect of daily oral PrEP use during pregnancy on bone mineral density among adolescent girls and young women in Uganda.

Zewdie K, Kiweewa F, Ssebuliba T, Morrison S, Muwonge T, Boyer J Front Reprod Health. 2024; 5:1240990.

PMID: 38260049 PMC: 10801233. DOI: 10.3389/frph.2023.1240990.


Lumbar spine bone mineral density in women breastfeeding for a period of 4 to 6 months: systematic review and meta-analysis.

Ferreira L, Tirapeli K, Silva C, Goldberg T Int Breastfeed J. 2023; 18(1):68.

PMID: 38111005 PMC: 10729562. DOI: 10.1186/s13006-023-00607-8.